相似文献
1
Reduced Production of Bacterial Membrane Vesicles Predicts Mortality in ST45/USA600 Methicillin-Resistant Bacteremia.
Antibiotics (Basel). 2019 Dec 18;9(1):2. doi: 10.3390/antibiotics9010002.
2
Australian Group on Antimicrobial Resistance (AGAR) Australian Staphylococcus aureus Sepsis Outcome Programme (ASSOP) Annual Report 2018.
Commun Dis Intell (2018). 2020 Mar 16;44. doi: 10.33321/cdi.2020.44.18.
3
Australian Group on Antimicrobial Resistance (AGAR) Australian Staphylococcus aureus Sepsis Outcome Programme (ASSOP) Annual Report 2017.
Commun Dis Intell (2018). 2019 Sep 16;43. doi: 10.33321/cdi.2019.43.43.
4
Epidemiology and outcomes of community-associated methicillin-resistant Staphylococcus aureus infection.
J Clin Microbiol. 2007 Jun;45(6):1705-11. doi: 10.1128/JCM.02311-06. Epub 2007 Mar 28.
5
Molecular characteristics of methicillin-resistant Staphylococcus aureus (MRSA) strains isolated from patients with bacteremia based on MLST, SCCmec, spa, and agr locus types analysis.
Microb Pathog. 2017 Mar;104:328-335. doi: 10.1016/j.micpath.2017.01.055. Epub 2017 Feb 1.
6
[Evaluation of methicillin-resistant Staphylococcus aureus bacteremia and comparison of prognosis according to vancomycin MIC values: experience of the last ten years].
Mikrobiyol Bul. 2013 Apr;47(2):199-210. doi: 10.5578/mb.4530.
7
Australian Staphylococcus aureus Sepsis Outcome Programme annual report, 2013.
Commun Dis Intell Q Rep. 2014 Dec 31;38(4):E309-19.
8
Comparison of community-acquired methicillin-resistant Staphylococcus aureus bacteremia to other staphylococcal species in a neonatal intensive care unit.
Eur J Pediatr. 2007 Apr;166(4):319-25. doi: 10.1007/s00431-006-0238-5. Epub 2006 Oct 19.
9
Methicillin-resistant Staphylococcus aureus bacteremia in hemodialysis and nondialysis patients.
J Microbiol Immunol Infect. 2014 Feb;47(1):15-22. doi: 10.1016/j.jmii.2012.08.015. Epub 2012 Oct 3.
10
Methicillin-resistant Staphylococcus aureus (MRSA) bacteremia: Correlations between clinical, phenotypic, genotypic characteristics and mortality in a tertiary teaching hospital in Malaysia.
Infect Genet Evol. 2018 Apr;59:132-141. doi: 10.1016/j.meegid.2018.01.031. Epub 2018 Feb 6.
引用本文的文献
1
Bacterial extracellular vesicles: emerging mediators of gut-liver axis crosstalk in hepatic diseases.
Front Cell Infect Microbiol. 2025 Jun 20;15:1620829. doi: 10.3389/fcimb.2025.1620829. eCollection 2025.
2
Bacterial Membrane Vesicles: Physiological Roles, Infection Immunology, and Applications.
Adv Sci (Weinh). 2023 Sep;10(25):e2301357. doi: 10.1002/advs.202301357. Epub 2023 Jun 25.
3
Eradication of Biofilm-Mediated Methicillin-Resistant Staphylococcus aureus Infections : Bacteriophage-Antibiotic Combination.
Microbiol Spectr. 2022 Apr 27;10(2):e0041122. doi: 10.1128/spectrum.00411-22. Epub 2022 Mar 29.
4
membrane vesicles contain immunostimulatory DNA, RNA and peptidoglycan that activate innate immune receptors and induce autophagy.
J Extracell Vesicles. 2021 Apr;10(6):e12080. doi: 10.1002/jev2.12080. Epub 2021 Apr 1.
5
Prolonged Exposure to β-Lactam Antibiotics Reestablishes Susceptibility of Daptomycin-Nonsusceptible Staphylococcus aureus to Daptomycin.
Antimicrob Agents Chemother. 2020 Aug 20;64(9). doi: 10.1128/AAC.00890-20.
6
Bacteriophage-Antibiotic Combination Strategy: an Alternative against Methicillin-Resistant Phenotypes of Staphylococcus aureus.
Antimicrob Agents Chemother. 2020 Jun 23;64(7). doi: 10.1128/AAC.00461-20.
本文引用的文献
1
Defining the Breakpoint Duration of Staphylococcus aureus Bacteremia Predictive of Poor Outcomes.
Clin Infect Dis. 2020 Feb 3;70(4):566-573. doi: 10.1093/cid/ciz257.
2
Clinical Data on Daptomycin plus Ceftaroline versus Standard of Care Monotherapy in the Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia.
Antimicrob Agents Chemother. 2019 Apr 25;63(5). doi: 10.1128/AAC.02483-18. Print 2019 May.
3
Vital Signs: Epidemiology and Recent Trends in Methicillin-Resistant and in Methicillin-Susceptible Staphylococcus aureus Bloodstream Infections - United States.
MMWR Morb Mortal Wkly Rep. 2019 Mar 8;68(9):214-219. doi: 10.15585/mmwr.mm6809e1.
4
Protection against Staphylococcus aureus bacteremia-induced mortality depends on ILC2s and eosinophils.
JCI Insight. 2019 Mar 21;4(6). doi: 10.1172/jci.insight.124168.
5
Gram-Positive Bacterial Extracellular Vesicles and Their Impact on Health and Disease.
Front Microbiol. 2018 Jul 9;9:1502. doi: 10.3389/fmicb.2018.01502. eCollection 2018.
6
Release of Staphylococcus aureus extracellular vesicles and their application as a vaccine platform.
Nat Commun. 2018 Apr 11;9(1):1379. doi: 10.1038/s41467-018-03847-z.
7
Staphylococcus aureus strategies to evade the host acquired immune response.
Int J Med Microbiol. 2018 Aug;308(6):625-630. doi: 10.1016/j.ijmm.2017.09.013. Epub 2017 Sep 15.
8
Increased Endovascular Staphylococcus aureus Inoculum Is the Link Between Elevated Serum Interleukin 10 Concentrations and Mortality in Patients With Bacteremia.
Clin Infect Dis. 2017 May 15;64(10):1406-1412. doi: 10.1093/cid/cix157.
9
Staphylococcus aureus inactivates daptomycin by releasing membrane phospholipids.
Nat Microbiol. 2016 Oct 24;2:16194. doi: 10.1038/nmicrobiol.2016.194.
10
Staphylococcus aureus Pathogenesis: The Importance of Reduced Cytotoxicity.
Trends Microbiol. 2016 Sep;24(9):681-682. doi: 10.1016/j.tim.2016.07.003. Epub 2016 Jul 19.
Zotero 插件
